CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma - Reply

被引：0
|
作者：
Doorduijn, JK [1 ]
Sonneveld, P [1 ]
机构：
[1] Erasmus MC, Dept Hematol, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 21期
关键词：
D O I：
10.1200/JCO.2005.014464
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4799 / 4800
页数：2
相关论文
共 50 条
  • [21] Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphoma: A pilot study for a leukocyte count oriented regimen
    Sawada, KI
    Sato, N
    Kohno, M
    Hannda, H
    Yasukouchi, T
    Tanngo, M
    Hirayama, A
    Koike, T
    LEUKEMIA & LYMPHOMA, 1995, 20 (1-2) : 103 - 109
  • [22] Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma
    Limat, S
    Demesmay, K
    Voillat, L
    Bernard, Y
    Deconinck, E
    Brion, A
    Sabbah, A
    Woronoff-Lemsi, MC
    Cahn, JY
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 277 - 281
  • [23] Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma
    Hanaoka, Kohei
    Hosono, Makoto
    Usami, Kimio
    Tatsumi, Yoichi
    Yamazoe, Yuzuru
    Komeya, Yoshihiro
    Tsuchiya, Norio
    Ishii, Kazunari
    Sumita, Mitsugu
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (08) : 678 - 683
  • [24] Use of Granulocyte Colony-Stimulating Factor and Neutropenic Events among Breast Cancer and Non-Hodgkin's Lymphoma Patients
    Lin, Wan-Ting
    Wen, Tsun-Jen
    Chiang, Shao-Chin
    Shen, Li-Jiuan
    Hsiao, Fei-Yuan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 243 - 244
  • [25] Intensified chop (CHOP14) plus rituximab in the treatment of elderly patients with aggressive and high risk non Hodgkin's lymphoma (NHL).
    Rigacci, L
    Nassi, L
    Alterini, R
    Carrai, V
    Bernardi, F
    Martini, V
    Bernardeschi, P
    Longo, G
    Bosi, A
    Morfini, M
    BLOOD, 2004, 104 (11) : 228B - 228B
  • [26] Risk factors for neutropenic fever in non-Hodgkin's lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis
    Kim, Yu Ri
    Kim, Soo-Jeong
    Park, Yong
    Oh, Sung Yong
    Yun, Hwan-Jung
    Mun, Yeung-Chul
    Kim, Jin Seok
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (05) : 1181 - 1189
  • [27] Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma -: a phase II study
    Späth-Schwalbe, E
    Lange, C
    Genvresse, I
    Krüuger, L
    Eucker, J
    Schweigert, M
    Sezer, O
    Budach, V
    Possinger, K
    ANTI-CANCER DRUGS, 2002, 13 (04) : 395 - 403
  • [28] Non-Hodgkin's lymphoma trials in elderly look beyond CHOP
    McNeil, C
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (04) : 266 - 267
  • [29] Efficacy of the colony-stimulating factors (CSFs) in elderly patients with aggressive non-Hodgkin's lymphoma (NHL): A meta-analysis.
    Agboola, O
    Balducci, L
    Dale, D
    Crawford, J
    Lyman, GH
    BLOOD, 2002, 100 (11) : 779A - 779A
  • [30] Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma
    Wolf, Max
    Bentley, Mark
    Marlton, Paula
    Horvath, Noemi
    Lewis, Ian D.
    Spencer, Andrew
    Herrmann, Richard
    Arthur, Chris
    Durrant, Simon
    Van Kerkhoven, Marilyn
    Macmillan, Jamie
    Mrongovius, Robert
    LEUKEMIA & LYMPHOMA, 2006, 47 (11) : 2344 - 2350
12345